Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.

Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol (2006) 4.02

Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed) (1983) 4.00

Residential environments and cardiovascular risk. J Urban Health (2003) 4.00

Diet and overall survival in elderly people. BMJ (1995) 3.73

Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. Br Med J (Clin Res Ed) (1984) 3.62

Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ (1996) 3.27

Dietary reduction of serum cholesterol concentration: time to think again. BMJ (1991) 3.10

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00

Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. Imperial Cancer Research Fund OXCHECK Study Group. BMJ (1994) 2.28

Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev (2006) 2.04

Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr (2004) 1.98

Strategies for preventing and screening for coronary heart disease. Br Heart J (1985) 1.96

Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while? BMJ (1991) 1.60

Incubation period of coronary heart disease. Br Med J (Clin Res Ed) (1982) 1.57

Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut (2007) 1.57

Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev (2011) 1.57

Trends in mortality among California physicians after giving up smoking: 1950-79. Br Med J (Clin Res Ed) (1983) 1.57

Missed opportunities for the prevention of cardiovascular disease among British hypertensives in primary care. Br J Gen Pract (1996) 1.55

Advising patients about low-fat diets. Can Fam Physician (1993) 1.53

First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX). BMC Public Health (2010) 1.50

Current issues in the design and interpretation of clinical trials. Br Med J (Clin Res Ed) (1985) 1.49

Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Canadian Task Force on the Periodic Health Examination. CMAJ (1993) 1.48

Association of smoking status with health-related outcomes after percutaneous coronary intervention. Circ Cardiovasc Interv (2015) 1.48

The impact of health care advice given in primary care on cardiovascular risk. CELL Study Group. BMJ (1995) 1.45

Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. Br Med J (Clin Res Ed) (1985) 1.44

Cholesterol and diet. Arch Dis Child (1989) 1.43

Lipid screening in family practice: a critical appraisal of recent evidence. Can Fam Physician (1986) 1.38

Hypercholesterolaemia and coronary heart disease: an answer. Br Med J (Clin Res Ed) (1984) 1.36

The Tromsø heart study: coffee consumption and serum lipid concentrations in men with hypercholesterolaemia: an randomised intervention study. Br Med J (Clin Res Ed) (1985) 1.31

Prevention and the elderly: risk factors. Health Serv Res (1985) 1.27

Treatment options for central retinal artery occlusion. Curr Treat Options Neurol (2013) 1.26

Impact of an occupational health promotion program on subsequent illness and mortality experience. Int Arch Occup Environ Health (2010) 1.16

Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials. Am J Public Health (1997) 1.16

An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Environ Microbiol (2003) 1.15

Scottish hearts but British habits. BMJ (1989) 1.15

Epidemiology of hypertension and associated cardiovascular risk factors in a country in transition: a population based survey in Tirana City, Albania. J Epidemiol Community Health (2003) 1.11

Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias. CMAJ (1990) 1.08

Trends in educational inequalities in cardiovascular risk factors: a longitudinal study among 48,000 middle-aged Norwegian men and women. Eur J Epidemiol (2006) 1.03

The lipoproteins: predictors, protectors, and pathogens. Br Med J (Clin Res Ed) (1983) 1.02

The impact of preventive cardiology on coronary artery disease. CMAJ (1988) 1.01

Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care (2008) 0.98

The Multifactor Primary Prevention Trial in Göteborg, Sweden. Comparison with a previously untreated population sample. Drugs (1986) 0.97

Does control of risk factors prevent coronary heart disease? Br Med J (Clin Res Ed) (1982) 0.97

Primary prevention trials in cardiovascular disease. J Epidemiol Community Health (1990) 0.95

Evaluation in health education. A review of progress, possibilities, and problems. J Epidemiol Community Health (1990) 0.93

Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis. Br Heart J (1993) 0.93

Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice. Scand J Prim Health Care (2009) 0.93

Global perspective on acute coronary syndrome: a burden on the young and poor. Circ Res (2014) 0.93

Evaluation of a self-help dietary intervention in a primary care setting. Am J Public Health (1992) 0.92

Dietary fatty acids in the secondary prevention of coronary heart disease: a systematic review, meta-analysis and meta-regression. BMJ Open (2014) 0.87

Dietary approaches for management of cardio-vascular health- a review. J Food Sci Technol (2012) 0.86

Physicians as patient teachers. West J Med (1984) 0.85

The drug treatment of mild hypertension in the Multiple Risk Factor Intervention Trial. A review. Drugs (1986) 0.84

Effect of smoking habits and timolol treatment on mortality and reinfarction in patients surviving acute myocardial infarction. Br Heart J (1985) 0.83

Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose. Wien Klin Wochenschr (2011) 0.83

Ischaemic heart disease and prodromes of sudden cardiac death. Is it possible to identify high risk groups for sudden cardiac death? Br Heart J (1985) 0.82

Physical distress is associated with cardiovascular events in a high risk population of elderly men. BMC Cardiovasc Disord (2009) 0.81

Linoleic acid and risk of sudden cardiac death. Br Heart J (1993) 0.80

Dietary fat and coronary heart disease. Br Heart J (1987) 0.80

Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Royal College of General Practitioners. Occas Pap R Coll Gen Pract (1992) 0.79

Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine. Nutr Metab (Lond) (2006) 0.79

Dietary intake of Americans reporting adherence to a low cholesterol diet (NHANES II). Am J Public Health (1990) 0.79

The current status of primary prevention in coronary heart disease. Curr Control Trials Cardiovasc Med (2001) 0.79

Mortality after remote surgery for benign gastroduodenal disease. Gut (1995) 0.78

Coronary care physician 1994-2000 adherence to 1993 National Cholesterol Education Program diet and lipid recommendations. J Natl Med Assoc (2001) 0.78

The most cited authors and papers in tobacco control. Tob Control (2005) 0.78

The Effects of Health Education through Face To Face Teaching and Educational Movies, on Suburban Women in Childbearing Age. Iran J Public Health (2010) 0.78

Primary prevention of coronary heart disease in the Federal Republic of Germany. Analysis of cost-effectiveness. Drugs (1990) 0.77

Decreasing cholesterol levels in the community--lifestyle change with statin? BMC Fam Pract (2015) 0.77

Lipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplasty. Tex Heart Inst J (1992) 0.77

CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-fat diet on cardiovascular disease in coronary patients. Am Heart J (2016) 0.77

Dietary fibers and cardiometabolic diseases. Int J Mol Sci (2012) 0.77

Cardiovascular risk determination: discrepancy between total cholesterol evaluation and two compound laboratory indices in Norway. J Epidemiol Community Health (1994) 0.76

The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. Int J Behav Nutr Phys Act (2015) 0.76

Dietary and pharmacologic management of cholesterol. Tex Heart Inst J (1990) 0.75

Dietary reduction of serum cholesterol concentration. BMJ (1991) 0.75

A review of clinical trials in dietary interventions to decrease the incidence of coronary artery disease. Curr Control Trials Cardiovasc Med (2001) 0.75

Multiple risk factor intervention trial produces an unexpected result. Can Med Assoc J (1983) 0.75

Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome. Mediators Inflamm (2015) 0.75

A systematic review and narrative summary of family-based smoking cessation interventions to help adults quit smoking. BMC Fam Pract (2016) 0.75

End of static decade for coronary disease? Br Med J (Clin Res Ed) (1984) 0.75

The cholesterol controversy. BMJ (1992) 0.75

An association between hypocholesterolaemia and colorectal carcinoma in an Irish population. Gut (1992) 0.75

Food propagandists--the new puritans. J R Coll Gen Pract (1985) 0.75

[Dietary treatment of mild to moderate hypercholesterolemia. Effectiveness of different interventions]. Can Fam Physician (1996) 0.75

Debate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl" Curr Control Trials Cardiovasc Med (2001) 0.75

Hypocholesterolaemia and cancer? Br Med J (Clin Res Ed) (1983) 0.75

Familial hypercholesterolaemia. J R Coll Gen Pract (1985) 0.75

Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia. J R Soc Med (1986) 0.75

Strategies for dietary and anti-smoking advice. Practical experiences from the Oslo Study. Drugs (1988) 0.75

Experiences from hypertension trials. Impact of other risk factors. Drugs (1988) 0.75

Cholesterol reduction and coronary artery disease. An overview of clinical trials up to 1986. Drugs (1988) 0.75

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet (2001) 6.31

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Benefit of a stroke unit: a randomized controlled trial. Stroke (1991) 3.13

The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med (1990) 2.85

Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ (1999) 2.73

Coronary risk factors and socioeconomic status. The Oslo study. Lancet (1976) 2.67

Risk factors for sports injuries--a methodological approach. Br J Sports Med (2003) 2.59

Four-year mortality by some socioeconomic indicators: the Oslo study. J Epidemiol Community Health (1980) 2.48

Lung cancer and air pollution: a 27 year follow up of 16 209 Norwegian men. Thorax (2003) 2.43

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome. Scand J Gastroenterol (2004) 2.37

The Oslo study. Cardiovascular disease in middle-aged and young Oslo men. Acta Med Scand Suppl (1975) 2.30

Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35-49 years. J Clin Epidemiol (1993) 2.28

The Oslo diet-heart study. Eleven-year report. Circulation (1970) 2.10

Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J (1997) 2.07

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer (1981) 2.06

Prevention of hamstring strains in elite soccer: an intervention study. Scand J Med Sci Sports (2007) 2.03

The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine (Phila Pa 1976) (1993) 2.01

Preventing injuries in female youth football--a cluster-randomized controlled trial. Scand J Med Sci Sports (2008) 1.90

The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Med Scand Suppl (1966) 1.80

Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet (1980) 1.75

Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction. Eur J Echocardiogr (2002) 1.69

Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure. Acta Med Scand (1976) 1.60

Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function. Eur Heart J (2002) 1.53

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br Med J (1978) 1.50

Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol (2006) 1.46

Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma. Arteriosclerosis (1990) 1.46

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study. Am J Med (1978) 1.42

Childhood traumas and psychosocial characteristics of 50-year-old men with essential hypertension. J Psychosom Res (1990) 1.42

[Doxazosin (Carduran)--a research survey]. Tidsskr Nor Laegeforen (1993) 1.39

[Alpha blockaders--first or second line antihypertensive agents?]. Tidsskr Nor Laegeforen (1993) 1.38

Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem (1998) 1.37

Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord (1994) 1.36

Oslo Study Diet and Antismoking Trial. Results after 102 months. Am J Med (1986) 1.35

Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study. Stroke (1993) 1.31

The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med (2006) 1.29

Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention. Diabetologia (2005) 1.28

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care (1997) 1.27

Association of cardiac autonomic function and the development of hypertension: the ARIC study. Am J Hypertens (1996) 1.26

Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. Biochem Pharmacol (1978) 1.23

Physical activity at work and at leisure in relation to coronary risk factors and social class. A 4-year mortality follow-up. The Oslo study. Acta Med Scand (1981) 1.22

Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study. Scand J Med Sci Sports (2007) 1.19

Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. J Intern Med (1998) 1.18

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis (2010) 1.17

Coronary risk factors in various occupational groups: the Oslo study. Br J Prev Soc Med (1977) 1.16

Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. Am J Epidemiol (1989) 1.16

Possible metabolic side effects of beta-adrenergic blocking drugs. Br Med J (1978) 1.14

The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men. Prev Med (1985) 1.12

Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT. JAMA (1984) 1.10

High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. Artery (1979) 1.09

Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo study. Am J Epidemiol (1980) 1.08

A randomized primary preventive trial in coronary heart disease: the Oslo study. Prev Med (1983) 1.08

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry (2001) 1.05

Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. J Epidemiol Community Health (1996) 1.03

MAPHY and the two arms of HAPPHY. JAMA (1989) 1.01

Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr (2001) 0.99

The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study. Acta Med Scand (1976) 0.97

[Mortality of Norwegian physicians in the period 1953-72 in relation to their smoking habits in 1952-3]. Tidsskr Nor Laegeforen (1976) 0.97

Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology (1999) 0.97

Assessment of volar angulation and shortening in 5th metacarpal neck fractures: an inter- and intra-observer validity and reliability study. J Hand Surg Eur Vol (2012) 0.97

Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. Scand J Med Sci Sports (2007) 0.97